CHA Vaccine Institute Co. Ltd.
Cha Vaccine Research Institute Co., Ltd., a research-oriented biotechnology company, researches and develops a range of vaccine products for infectious and chronic diseases. Its product pipeline includes HBV vaccine that is in Phase IIb planning for the prevention of hepatitis B; Adjuvanted HBV vaccine that is in Phase I/IIa for the treatment of chronic hepatitis B; and VZV Vaccine, which is in p… Read more
Market Cap & Net Worth: CHA Vaccine Institute Co. Ltd. (261780)
CHA Vaccine Institute Co. Ltd. (KQ:261780) has a market capitalization of $57.61 Million (₩84.36 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23021 globally and #1215 in its home market, demonstrating a 21.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CHA Vaccine Institute Co. Ltd.'s stock price ₩3140.00 by its total outstanding shares 26865246 (26.87 Million).
CHA Vaccine Institute Co. Ltd. Market Cap History: 2021 to 2026
CHA Vaccine Institute Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $203.66 Million to $57.61 Million (-27.58% CAGR).
Index Memberships
CHA Vaccine Institute Co. Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #589 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #589 of 1384 |
Weight: CHA Vaccine Institute Co. Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CHA Vaccine Institute Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CHA Vaccine Institute Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.15x
CHA Vaccine Institute Co. Ltd.'s market cap is 0.15 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $203.66 Million | $500.00 Million | -$18.42 Billion | 0.41x | N/A |
| 2022 | $91.46 Million | $179.48 Million | -$6.72 Billion | 0.51x | N/A |
| 2023 | $103.67 Million | $294.12 Million | -$1.75 Billion | 0.35x | N/A |
| 2024 | $56.15 Million | $370.66 Million | -$10.14 Billion | 0.15x | N/A |
Competitor Companies of 261780 by Market Capitalization
Companies near CHA Vaccine Institute Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to CHA Vaccine Institute Co. Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CHA Vaccine Institute Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, CHA Vaccine Institute Co. Ltd.'s market cap moved from $203.66 Million to $ 57.61 Million, with a yearly change of -27.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩57.61 Million | +11.15% |
| 2025 | ₩51.83 Million | -7.68% |
| 2024 | ₩56.15 Million | -45.84% |
| 2023 | ₩103.67 Million | +13.34% |
| 2022 | ₩91.46 Million | -55.09% |
| 2021 | ₩203.66 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CHA Vaccine Institute Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $57.61 Million USD |
| MoneyControl | $57.61 Million USD |
| MarketWatch | $57.61 Million USD |
| marketcap.company | $57.61 Million USD |
| Reuters | $57.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.